Envoy Medical, Inc. (NASDAQ:COCH) Short Interest Update

Envoy Medical, Inc. (NASDAQ:COCH) was the target of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 355,300 shares, a growth of 657.6% from the October 31st total of 46,900 shares. Currently, 4.6% of the company’s stock are sold short. Based on an average trading volume of 231,200 shares, the days-to-cover ratio is presently 1.5 days.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on COCH. Brookline Capital Management began coverage on Envoy Medical in a research note on Monday, October 14th. They set a “buy” rating and a $9.00 target price on the stock. Ascendiant Capital Markets boosted their target price on Envoy Medical from $8.50 to $8.75 and gave the stock a “buy” rating in a research note on Tuesday, September 3rd.

Envoy Medical Stock Performance

COCH traded down $0.01 on Friday, reaching $2.28. 19,275 shares of the stock were exchanged, compared to its average volume of 199,662. The company’s 50-day moving average price is $2.60 and its 200 day moving average price is $2.61. Envoy Medical has a fifty-two week low of $1.08 and a fifty-two week high of $11.46.

Institutional Trading of Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. Virtu Financial LLC purchased a new position in shares of Envoy Medical, Inc. (NASDAQ:COCH) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,045 shares of the company’s stock, valued at approximately $55,000. Virtu Financial LLC owned 0.07% of Envoy Medical as of its most recent filing with the Securities and Exchange Commission. 8.59% of the stock is owned by hedge funds and other institutional investors.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.